Related Experiment Video
Updated: Feb 28, 2026

A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
Olfactory dysfunction in patients with primary progressive MS
Felix A Schmidt1, Matthew B Maas1, Rohat Geran1
1Clinical and Experimental Multiple Sclerosis Research Center (F.A.S., R.G., H.K., K.R., F.P., L.H.), Department of Neurology, NeuroCure Clinical Research Center (F.A.S., F.P.), Department of Psychiatry (C.S.), Department of Audiology and Phoniatrics (Ö.G.), Charité-Universitätsmedizin Berlin (F.P.), Germany; Department of Neurology (M.B.M.), Feinberg School of Medicine, Northwestern University, Chicago, IL; MSB Medical School Berlin (H.K.), Germany; and Experimental and Clinical Research Center (F.P.), Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Objective:
We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS).
Methods:
Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs). Patients with olfactory dysfunction due to an alternative primary etiology were excluded. The validated olfactory testing method yielded individual scores for olfactory threshold, odor discrimination, and odor identification, along with a composite Threshold Discrimination Identification (TDI) score.
Results:
Olfactory dysfunction was identified in 27 (84%) patients with PPMS, 10 (31%) patients with RRMS, and 1 (3%) HC. While age and sex were similar between PPMS and HCs, the TDI score and all olfactory subscores were significantly worse in patients with PPMS compared with HCs (all p < 0.001). After adjustment for differences in age, sex, Expanded Disability Status Scale (EDSS), and disease duration, odor discrimination, odor identification, and the composite TDI score were worse in patients with PPMS vs RRMS (p = 0.03, 0.04, and 0.02, respectively). Neither age, sex, EDSS, nor disease duration was significantly associated with the composite TDI score.
Conclusions:
Olfactory dysfunction was more frequent and severe in PPMS compared with RRMS, independent of disease duration and overall disability status. Further research on cellular level differences in olfactory neural pathways may lead to new insights about disease pathogenesis in MS.
Insights
Patients with primary progressive multiple sclerosis (PPMS) experience more severe olfactory dysfunction than those with relapsing-remitting multiple sclerosis (RRMS). This impairment is independent of disease duration and disability.
Area of Science:
- Neurology
- Neuroscience
- Olfactory research
Background:
- Olfactory dysfunction is a potential early symptom in multiple sclerosis (MS).
- The impact of different MS subtypes on olfactory function requires further investigation.
Purpose of the Study:
- To compare olfactory function between patients with primary progressive multiple sclerosis (PPMS) and relapsing-remitting multiple sclerosis (RRMS).
- To assess the prevalence and severity of olfactory dysfunction in PPMS versus RRMS.
Main Methods:
- Standardized olfactory testing, including threshold, discrimination, and identification, was conducted in 32 PPMS patients, 32 RRMS patients, and 32 healthy controls (HCs).
- Exclusion criteria targeted patients with alternative causes of olfactory dysfunction.
- A composite Threshold Discrimination Identification (TDI) score was calculated.
Main Results:
- A high prevalence of olfactory dysfunction was observed: 84% in PPMS, 31% in RRMS, and 3% in HCs.
- Patients with PPMS showed significantly worse olfactory function (TDI score and subscores) compared to HCs (p < 0.001).
- After adjusting for age, sex, EDSS, and disease duration, PPMS patients still exhibited worse odor discrimination, odor identification, and TDI scores than RRMS patients (p = 0.02-0.04).
Conclusions:
- Olfactory dysfunction is more frequent and severe in PPMS compared to RRMS.
- These olfactory deficits in PPMS are not explained by disease duration or disability (EDSS).
- Investigating cellular differences in olfactory pathways may elucidate MS pathogenesis.
Related Concept Videos
Olfactory Receptors: Location and Structure
Olfaction
The olfactory receptors are embedded in the cilia of the...
Physiology of Smell and Olfactory Pathway
The olfactory...
Taste Buds and Receptors
Parkinson's Disease: Overview
Prosopagnosia

